AVE — Avecho Biotechnology Share News
0.000.00%
Last trade - 00:00- AU$55.10m
- AU$50.45m
- AU$1.24m
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
Brief: Avecho Biotechnology Seeks Trading Halt Pending Release Of Information About License And Development Agreement
Brief: Avecho Biotechnology Says Receives Ethics Approval For Amendments To Phase III Insomnia Clinical Trial
Brief: Avecho Biotechnology Says Avecho Conducts A$6M Placement
Brief: Avecho Biotechnology Seeks Trading Halt
Brief: Avecho Biotechnology Signs Licensing And Development Agreement With Arthur Group Llc
Brief: Avecho Biotechnology Says Undertaking A Capital Raise
Australia's Avecho Biotech up on Vit. K injection development progress
Australia's Avecho Biotechnology up on ethics nod for insomnia drug trial
Australia's Avecho Biotech jumps on Perrigo deal to develop gel for U.S.
Brief: Avecho Biotechnology Signs Agreement With Perrigo Company Plc
Australia Stock Exchange release from AVECHO BIOTECHNO : Positive results from AVE's topical CBD pain study
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 09:33:02
Australia Stock Exchange release from AVECHO BIOTECHNO : Dosing begins in topical CBD pain study
Australia Stock Exchange release from AVECHO BIOTECHNO : PRE_NR Ends: 08:55:12
Australia Stock Exchange release from AVECHO BIOTECHNO : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from AVECHO BIOTECHNO : Appendix 4E and Annual Report 31 December 2021